HomeTOVX • NYSEAMERICAN
Theriva Biologics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.40M | -25.23% |
Net income | -4.45M | 18.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.37M | 25.19% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.61M | -49.91% |
Total assets | 35.35M | -35.98% |
Total liabilities | 16.29M | 4.92% |
Total equity | 19.07M | — |
Shares outstanding | 2.78M | — |
Price to book | 0.17 | — |
Return on assets | -29.12% | — |
Return on capital | -46.75% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.45M | 18.92% |
Cash from operations | -4.69M | 28.28% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 7.00K | 100.48% |
Net change in cash | -4.81M | 39.75% |
Free cash flow | -3.84M | 38.01% |
Previous close
$1.18
Day range
$1.07 - $1.18
Year range
$1.03 - $12.28
Market cap
3.17M USD
Avg Volume
24.93K
P/E ratio
-
Dividend yield
-
About
Founded
1986
Headquarters
Website
Employees
22
